Corrigendum to "Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma" [Eur J Cancer 126 (2020) 93-103].
Eur J Cancer
; 184: 199, 2023 May.
Article
in En
| MEDLINE
| ID: mdl-36868971
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2023
Type:
Article